Trial Outcomes & Findings for Natural Orifice Transgastric Endoscopic (NOTES) Transgastric Diagnostic Peritoneoscopy With Laparoscopic Assistance (NCT NCT00962650)

NCT ID: NCT00962650

Last Updated: 2012-03-29

Results Overview

Number of participants in which transgastric access was achieved using the EES NOTES GEN1 Toolbox Outcome description: Completion of diagnostic peritoneoscopy after transgastric access was completed using a flexible, steerable trocar. Because this was a feasibility trial, transgastric access was the primary outcome.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

7 participants

Primary outcome timeframe

Assessed intra-operatively as the time from first insertion of the flexible trocar into the oral cavity to final withdrawal of the flexible trocar

Results posted on

2012-03-29

Participant Flow

Study Initiation Date: 09 June 2009 (First Informed consent signed) Study Completion Date:03 May 2010 (Last subject last visit) Enrollment Location: The Ohio State University Medical Center

All enrolled subjects provided informed consent to participate in the study, met protocol entry criteria, and had the study procedure attempted (ITT population).

Participant milestones

Participant milestones
Measure
Natural Orifice Transgastric Diagnostic Peritineoscopy
Natural orifice transgastric diagnostic peritineoscopy refers to performing diagnostic peritineoscopy with laparoscopic assistance with access through the stomach instead of using a trocar placed through the skin.
Overall Study
STARTED
10
Overall Study
COMPLETED
8
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Natural Orifice Transgastric Diagnostic Peritineoscopy
Natural orifice transgastric diagnostic peritineoscopy refers to performing diagnostic peritineoscopy with laparoscopic assistance with access through the stomach instead of using a trocar placed through the skin.
Overall Study
Transgastric DP was not completed
2

Baseline Characteristics

Natural Orifice Transgastric Endoscopic (NOTES) Transgastric Diagnostic Peritoneoscopy With Laparoscopic Assistance

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Natural Orifice Transgastric Diagnostic Peritineoscopy
n=10 Participants
Natural orifice transgastric diagnostic peritineoscopy refers to performing diagnostic peritineoscopy with laparoscopic assistance with access through the stomach instead of using a trocar placed through the skin.
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
9 Participants
n=5 Participants
Age, Categorical
>=65 years
1 Participants
n=5 Participants
Age Continuous
54.2 years
STANDARD_DEVIATION 9.76 • n=5 Participants
Sex: Female, Male
Female
9 Participants
n=5 Participants
Sex: Female, Male
Male
1 Participants
n=5 Participants
Region of Enrollment
United States
10 participants
n=5 Participants

PRIMARY outcome

Timeframe: Assessed intra-operatively as the time from first insertion of the flexible trocar into the oral cavity to final withdrawal of the flexible trocar

Population: The subject pool was limited to individuals scheduled for Rouen Y gastric bypass(Intent to Treat population). There was no statistical analysis. Success was based on completion of the diagnostic peritineoscopy procedure after transgastric access.

Number of participants in which transgastric access was achieved using the EES NOTES GEN1 Toolbox Outcome description: Completion of diagnostic peritoneoscopy after transgastric access was completed using a flexible, steerable trocar. Because this was a feasibility trial, transgastric access was the primary outcome.

Outcome measures

Outcome measures
Measure
Natural Orifice Transgastric Diagnostic Peritineoscopy
n=10 Participants
Natural orifice transgastric diagnostic peritineoscopy refers to performing diagnostic peritineoscopy with laparoscopic assistance with access through the stomach instead of using a trocar placed through the skin.
Completion of Diagnostic Peritineoscopy
8 Participants

Adverse Events

Natural Orifice Transgastric Diagnostic Peritineoscopy

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Natural Orifice Transgastric Diagnostic Peritineoscopy
n=10 participants at risk
Natural orifice transgastric diagnostic peritineoscopy refers to performing diagnostic peritineoscopy with laparoscopic assistance with access through the stomach instead of using a trocar placed through the skin.
Surgical and medical procedures
ESOPHAGEAL INJURY/ OESOPHAGEAL INJURY
10.0%
1/10 • Number of events 1 • Adverse events were collected from Study Initiation Date (first Informed Consent signed) 09 June 2009 until Study Completion Date (last participant's last visit) on 03 May 2010.

Other adverse events

Adverse event data not reported

Additional Information

Michael Schwiers, Principal Biostatistician

Ethicon Endo-Surgery, Inc.

Phone: 513-337-1172

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place